Scripps Research

New Capabilities

As of May 2026: Core scientific partner on immunogen design; CHAVD funding ending 2026

In 1984, the U.S. Health Secretary predicted an HIV vaccine within two years. After four decades and dozens of failed trials, IAVI is dosing participants in South Africa with a vaccine that trains the immune system from the ground up rather than simply presenting viral proteins.

Updated May 22